Display options
Cite
García-Pérez FO, Davanzo J, López-Buenrostro S, et al. Head to head comparison performance of . Am J Nucl Med Mol Imaging. 2018;8(5):332-340
García-Pérez, F. O., Davanzo, J., López-Buenrostro, S., Santos-Cuevas, C., Ferro-Flores, G., Jímenez-Ríos, M. A., Scavuzzo, A., Santana-Ríos, Z., & Medina-Ornelas, S. (2018). Head to head comparison performance of . American journal of nuclear medicine and molecular imaging, 8(5), 332-340.
García-Pérez, Francisco Osvaldo, et al. "Head to head comparison performance of ." American journal of nuclear medicine and molecular imaging vol. 8,5 (2018): 332-340.
García-Pérez FO, Davanzo J, López-Buenrostro S, Santos-Cuevas C, Ferro-Flores G, Jímenez-Ríos MA, Scavuzzo A, Santana-Ríos Z, Medina-Ornelas S. Head to head comparison performance of . Am J Nucl Med Mol Imaging. 2018 Oct 20;8(5):332-340. eCollection 2018. PMID: 30510850; PMCID: PMC6261875.
Copy Download .nbib Format: NLM
Share it on

Am J Nucl Med Mol Imaging. 2018 Oct 20;8(5):332-340. eCollection 2018.

Head to head comparison performance of .

American journal of nuclear medicine and molecular imaging

Francisco Osvaldo García-Pérez, Jenny Davanzo, Sergio López-Buenrostro, Clara Santos-Cuevas, Guillermina Ferro-Flores, Miguel A Jímenez-Ríos, Anna Scavuzzo, Zael Santana-Ríos, Sevastián Medina-Ornelas

Affiliations

  1. Nuclear Medicine and Department of Molecular Imaging, Instituto Nacional de Cancerología Mexico City, Mexico.
  2. Department of Urologic Malignances, Instituto Nacional de Cancerología Mexico City, Mexico.
  3. Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares Estado de México, Mexico.

PMID: 30510850 PMCID: PMC6261875

Abstract

Positron emission tomography (PET) with prostate-specific membrane antigen (PSMA) has found widespread use for the diagnosis of biochemical recurrence of prostate cancer (PCa). Unfortunately, PET/CT is not as widely available; thus a PSMA-targeting compound for scintigraphy is of special interest. The aim of this study was to compare

Keywords: 68Ga-PSMA-11 PET/CT; 99mTc-HYNIC-PSMA; SPECT/CT; biochemical recurrence prostate cancer

Conflict of interest statement

None.

References

  1. J Nucl Med. 2014 Nov;55(11):1791-8 - PubMed
  2. Rev Esp Med Nucl Imagen Mol. 2018 Jul - Aug;37(4):223-228 - PubMed
  3. Nucl Med Biol. 2017 May;48:36-44 - PubMed
  4. Clin Nucl Med. 2017 Jan;42(1):26-33 - PubMed
  5. Radiology. 2005 May;235(2):623-8 - PubMed
  6. Histol Histopathol. 2004 Jul;19(3):715-8 - PubMed
  7. Nucl Med Biol. 2016 Aug;43(8):463-9 - PubMed
  8. Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1284-94 - PubMed
  9. J Nucl Med. 2013 Aug;54(8):1369-76 - PubMed
  10. Clin Nucl Med. 2016 Sep;41(9):e397-402 - PubMed
  11. Eur Urol. 2013 Jul;64(1):106-17 - PubMed
  12. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):965-74 - PubMed
  13. Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):197-209 - PubMed
  14. Am J Nucl Med Mol Imaging. 2017 Jan 15;7(1):1-11 - PubMed
  15. CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29 - PubMed
  16. J Nucl Med. 2015 Oct;56(10):1629-34 - PubMed
  17. Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):11-20 - PubMed
  18. Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):253-63 - PubMed
  19. Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1929-30 - PubMed
  20. Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):210-4 - PubMed

Publication Types